Debrecen, Hungary

Gyorgy Sulyok

This inventor holds 1 USPTO granted patent. Top assignee: Biogal Gyogyszergyar Rt.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gyorgy Sulyok. Retrieved from https://idiyas.com/inventor/gyorgy-sulyok

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gyorgy Sulyok: Innovator in Pharmaceutical Compounds

Introduction

Gyorgy Sulyok is a notable inventor based in Debrecen, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on Flavilium compounds.

Latest Patents

Gyorgy Sulyok holds one patent related to Flavilium compounds and their method of use. This invention pertains to a compound of a specific formula, wherein X is a pharmacologically acceptable anion. His work in this area showcases his commitment to advancing pharmaceutical science.

Career Highlights

Sulyok is associated with Biogal Gyogyszergyar Rt., a company known for its contributions to the pharmaceutical industry. His role there has allowed him to focus on developing new compounds that can potentially improve health outcomes.

Collaborations

He has collaborated with colleagues such as Janos Balint and Ildiko Borbely, contributing to a team effort in research and development within the pharmaceutical sector.

Conclusion

Gyorgy Sulyok's work exemplifies the spirit of innovation in the pharmaceutical field, and his contributions through his patent on Flavilium compounds highlight the importance of research in developing new medical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…